Invention Grant
- Patent Title: Quinazoline analogs as receptor tyrosine kinase inhibitors
-
Application No.: US16264194Application Date: 2019-01-31
-
Publication No.: US11174273B2Publication Date: 2021-11-16
- Inventor: Eli Wallace , George Topalov , Joseph Lyssikatos , Alexandre Buckmelter , Qian Zhao
- Applicant: Array BioPharma Inc.
- Applicant Address: US CO Boulder
- Assignee: Array BioPharma Inc.
- Current Assignee: Array BioPharma Inc.
- Current Assignee Address: US CO Boulder
- Agency: Viksnins Harris Padys Malen LLP
- Main IPC: A61K31/517
- IPC: A61K31/517 ; C07D498/10 ; C07D239/94 ; C07D401/12 ; C07D413/12 ; C07D413/14 ; C07D417/14 ; C07D498/04 ; A61P35/00 ; A61P29/00
Abstract:
The invention includes methods of using compounds of Formula I as type I receptor tyrosine kinase inhibitors and for the treatment of hyperproliferative diseases such as cancer.
Public/Granted literature
- US20210284656A9 QUINAZOLINE ANALOGS AS RECEPTOR TYROSINE KINASE INHIBITORS Public/Granted day:2021-09-16
Information query
IPC分类:
